Sports and Supervised Exercise Programmes for Children and Young Adults with Pulmonary Hypertension. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) and the Association for European Paediatric and Congenital Cardiology (AEPC)

COMMENTED

Interstitial Lung Disease

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Eur Respir J

Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM

doi: 10.1183/13993003.02533-2024

Pulmonary Hypertension

Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease

Chest

Garcia AR, Vollmer I, Blanco I, San José Estepar R, Rodriguez-Chiaradía DA, López-Meseguer M, Martin-Ontiyuelo C, Nardelli P, Hernandez-Gonzalez F, Bosacoma A, Ribas J, Pomares X, Santos S, Molina-Molina M, Sellares J, Rahaghi FN, Washko G, San José Estepar R, Barberà JA

doi: 10.1016/j.chest.2026.05.027

Pulmonary Hypertension

Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry

Ann Am Thorac Soc

McCarthy BE, Feng R, Bernardo R, Shlobin OA, De Marco T, Wichman T, Presberg KW, Ravichandran A, Horn EM, Elwing JM, George MP, Runo JR, Safdar Z, Ventetuolo CE, Al-Naamani N, PHAR investigators

doi: 10.1093/annalsats/aaoag141

RECOMMENDED

Interstitial Lung Disease

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med

Solomon JJ, Dieudé P, Matson SM, Lee JS, Rojas-Serrano J, Sebastiani M, Gonzalez A, Demoruelle MK, Hoffman-Vold AM, Kam MLW, Swigris JJ, Sparks JA, Brown KK, Cottin V, Kellermeyer LM, Wilson KC, Waseda Y, Crestani B, Walsh SLF, Poletti V, Doyle T, Koduri G, Kelly C, Danoff S, Dellaripa PF

doi: 10.1016/S2213-2600(26)00094-9

COPDPulmonary Hypertension

Pulmonary vasodilator therapy in COPD-associated pulmonary hypertension: A real-world case series of 14 patients confirmed by right heart catheterization

Respir Med Case Rep

Vera Ricaurte M, Kosak Lopez E, Geller A, Leguizamon R, Lam J, Srikulmontri T, Helena Siqueira Tavares de Melo M, Stavola T, Malin J, Martinez-Manzano JM, Pacheco E

doi: 10.1016/j.rmcr.2026.102443

RECOMMENDED

Interstitial Lung Disease

Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: A Pulmonary Perspective on Recent Guidelines

★ 1 Recommended by Dr. med. Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Adv Ther

Ozduygu G, Kaenmuang P, Guedes ABF, Amaral AF, Chaudhuri N

doi: 10.1007/s12325-026-03701-5

Pulmonary Hypertension

Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study

Adv Ther

Zisman D, Sahay S, Bandyopadhyay D, Al-Astal A, Broderick M, Caudell Stamper D, Champion H, DerSarkissian M, Hunsucker M, Lee D, Maher K, Nelsen A, Parikh R, Rahaghi F, Raval A, Thrasher CM, Kulkarni T, Shlobin OA, Kiely DG, Nathan S, Scholand MB

doi: 10.1007/s12325-026-03508-4

Further Publications

Adjunctive Effects of Pediatric Tuina on Symptoms, Inflammation, and Pulmonary Function in Children With Severe Pneumonia: A Randomized Controlled Trial

Pediatr Pulmonol

He T, Chen Y, Wen H, He L

doi: 10.1002/ppul.71404

RECOMMENDED

Pulmonary Hypertension

Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

Chest

Szwed P, Kurzyna P, Banaszkiewicz-Cyganik M, Kędzierski P, Łomiak M, Wolański R, Wasilewski M, Florczyk M, Piłka M, Torbicki A, Kurzyna M, Darocha S

doi: 10.1016/j.chest.2025.10.017

Related content

Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease

Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement

Pulmonary vasodilator therapy in COPD-associated pulmonary hypertension: A real-world case series of 14 patients confirmed by right heart catheterization

Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: A Pulmonary Perspective on Recent Guidelines

Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study

Adjunctive Effects of Pediatric Tuina on Symptoms, Inflammation, and Pulmonary Function in Children With Severe Pneumonia: A Randomized Controlled Trial

Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension